Financial reports
10-K/A
2023 FY
Annual report (amended)
12 Apr 24
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
26 Mar 24
8-K/A
Other Events
22 Mar 24
8-K
Other Events
20 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
15 Mar 24
8-K
Other Events
11 Mar 24
8-K
Regulation FD Disclosure
26 Jan 24
8-K
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
3 Jan 24
8-K
Entry into a Material Definitive Agreement
16 Nov 23
8-K
Q32 Bio and Homology Medicines Announce Merger Agreement
16 Nov 23
8-K
Regulation FD Disclosure
10 Oct 23
Registration and prospectus
Proxies
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
28 Apr 20
DEF 14A
Definitive proxy
28 Apr 20
DEFA14A
Additional proxy soliciting materials
25 Apr 19
DEF 14A
Definitive proxy
25 Apr 19
Other
EFFECT
Notice of effectiveness
15 Feb 24
EFFECT
Notice of effectiveness
20 Mar 23
CORRESP
Correspondence with SEC
16 Mar 23
UPLOAD
Letter from SEC
14 Mar 23
SEC STAFF
SEC staff action: Order
19 Apr 21
SEC STAFF
SEC staff action: Order
22 Mar 21
EFFECT
Notice of effectiveness
15 Mar 21
CT ORDER
Confidential treatment order
3 Feb 21
EFFECT
Notice of effectiveness
10 Apr 19
CORRESP
Correspondence with SEC
8 Apr 19
Ownership
4
Paul Alloway
23 Apr 24
4
Charles Michaud Jr
23 Apr 24
SC 13D
ACORN BIOVENTURES, L.P.
4 Apr 24
SC 13D
Atlas Venture Fund X, L.P.
1 Apr 24
SC 13G
Carlyle Group Inc.
29 Mar 24
SC 13D
ORBIMED ADVISORS LLC
28 Mar 24
4
ARTHUR TZIANABOS
27 Mar 24
4
Isaac Manke
27 Mar 24
4
Mark T Iwicki
27 Mar 24
4
DAVID S. GRAYZEL
27 Mar 24